Furthermore, pharmacological inhibition of the M-CSF receptor, c-fms, with GW2580, or immunological inhibition with an anti-c-fms antibody both retard the progression of atherosclerosis [22], [23]. This evidence concerns the gene CSF1R and atherosclerosis.